CDNA.NASDAQCaredx, INC

SCHEDULE: Vanguard Boosts CareDx Stake to 7.04%

Sentiment:

Beneficial Ownership Report


The Vanguard Group has increased its beneficial ownership in CareDx Inc to 7.04% of common stock as of September 30, 2025.

Summary

  • The Vanguard Group reported beneficial ownership of 3,749,707 shares of CareDx Inc common stock.
  • This represents 7.04% of the class of securities.
  • The filing is an Amendment No. 8 to a Schedule 13G.
  • The event date requiring this filing was September 30, 2025.
  • Vanguard holds sole dispositive power over 3,324,002 shares and shared dispositive power over 425,705 shares.
  • Vanguard holds shared voting power over 370,934 shares and no sole voting power.
  • The securities were acquired and are held in the ordinary course of business, not for influencing control of the issuer.

Sentiment

Score: 7

Explanation: The filing indicates increased institutional ownership by The Vanguard Group, which can be interpreted as a positive signal of confidence, though it provides no operational or financial performance details of the issuer.

Positives

  • Increased institutional ownership by a major investment firm like The Vanguard Group, which can be interpreted as a vote of confidence in CareDx Inc.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding CareDx Inc's operational or financial performance.

Industry Context

A significant increase in beneficial ownership by a prominent institutional investor like The Vanguard Group can signal growing institutional confidence in CareDx Inc or its sector, potentially attracting further investor interest.

Stakeholder Impact

  • Existing shareholders may view the increased institutional ownership as a positive indicator, potentially bolstering confidence in the company's long-term prospects.
  • Potential investors might be influenced by the backing of a major investment firm, leading to increased interest in CareDx Inc's stock.

Key Dates

DateDescription
09/30/2025Date of event requiring the filing of this statement.
10/30/2025Date of signing the Schedule 13G filing by The Vanguard Group.

Recommendation

hold

The increase in beneficial ownership by a major institutional investor like The Vanguard Group suggests a degree of confidence in CareDx Inc. However, this filing does not provide operational or financial performance data to warrant a stronger recommendation. Investors should hold and monitor for further company-specific news and financial results.

Keywords

CareDx Inc, Vanguard Group, Institutional Ownership, Schedule 13G, Common Stock, Beneficial Ownership, Investment Adviser

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.